Category Archives: Genetics

Can Fulgent Genetics Inc (FLGT) Stock Rise to the Top of Healthcare Sector? – InvestorsObserver

The 99 rating InvestorsObserver gives to Fulgent Genetics Inc (FLGT) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 86 percent of stocks in the Healthcare sector, FLGTs 99 overall rating means the stock scores better than 99 of all stocks.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Fulgent Genetics Inc (FLGT) stock is trading at $128.63 as of 10:05 AM on Wednesday, Feb 3, an increase of $15.79, or 14% from the previous closing price of $112.83. The stock has traded between $118.81 and $132.83 so far today. Volume today is below average. So far 343,509 shares have traded compared to average volume of 2,419,433 shares.

Click Here to get the full Stock Score Report on Fulgent Genetics Inc (FLGT) Stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

You May Also Like

Read more from the original source:
Can Fulgent Genetics Inc (FLGT) Stock Rise to the Top of Healthcare Sector? - InvestorsObserver

Genetic testing company 23andMe to go public via merger with Richard Branson’s SPAC in $3.5 billion deal – MarketWatch

23andMe, a consumer genetics company, is going public via a merger with Richard Branson's special purpose acquisition corporation (SPAC) VG Acquisition Corp. VGAC, +1.74%, in a deal with an enterprise value of about $3.5 billion, the companies said Thursday. SPACs,or blank-check companies, raise money in an initial public offering and then have two years to acquire a business or businesses. They have become a popular vehicle for IPOs during the pandemic. Once the deal has closed, the company will change its ticker symbol to "ME" and trade on the New York Stock Exchange. 23andMe co-Founder Anne Wojcicki and Branson are investing $25 million in the company, which will have a pro forma cash balance of more than $900 million at closing. 23andMe offers individuals the chance to have their genes tested, providing them with information on health risks and ancestry. "Through a genetics-based approach, we fundamentally believe we can transform the continuum of healthcare.," Wojcicki said in a statement. The deal is expected to close in the second quarter. VG Acquisition shares jumped 12% premarket on the news.

Read the rest here:
Genetic testing company 23andMe to go public via merger with Richard Branson's SPAC in $3.5 billion deal - MarketWatch

Paw Print Genetics Launches 46 New Tests for Inherited Diseases and Traits Found in Canines – PRNewswire

SPOKANE, Wash., Feb. 1, 2021 /PRNewswire/ --Paw Print Genetics, a division of Genetic Veterinary Sciences, Inc., has launched 46 new, highly desired disease and trait tests to their ever-growing menu of genetic assays. This menu now consists of nearly 300 different tests for over 350 different breeds of dog, the largest in the industry.

Among these are new tests for Labrador retrievers, Beagles, Collies and many other breeds. All tests offered at Paw Print Genetics are based on the published, medical literature, and developed and validated in their laboratory in Spokane, WA.

"We are very excited to provide these tests to our customer community of breeders, veterinarians and dog owners." stated Dr. Lisa Shaffer, CEO of Paw Print Genetics. "By offering the largest menu of tests available, Paw Print Genetics continues to be the leading provider of testing for genetic conditions in dogs. With our staff of geneticists and veterinarians, we provide genetic counseling services to fully support our customers in their testing."

These additional tests further Paw Print Genetics' mission to help breeders achieve optimal canine genetic health. Paw Print Genetics strictly follows the published standards and guidelines for canine clinical genetic testing laboratories.As such, all testing conducted by Paw Print Genetics is performed in duplicate with two independent methods, ensuring a 99.9% accuracy rate.

Learn more about these new test offerings here: https://www.pawprintgenetics.com/blog/2021/01/28/paw-print-genetics-launches-46-new-tests-dogs/

About Paw Print Genetics

Located in Spokane, Washington, Paw Print Genetics was founded in 2012 and is dedicated to raising the standard in canine genetic diagnostic testing, carrier screening, and customer support. Paw Print Genetics' mission is to achieve optimal canine genetic health by providing outstanding resources for dog owners, breeders, trainers, and veterinarians for pets, show dogs and working dogs. For more information, visit https://www.pawprintgenetics.com/

For more information regarding this topic, please contact Jessica Pieros at [emailprotected].

Contact: Jessica Pieros 509-483-5950 [emailprotected]

SOURCE Paw Print Genetics

View original post here:
Paw Print Genetics Launches 46 New Tests for Inherited Diseases and Traits Found in Canines - PRNewswire

EXCLUSIVE: THIS genetic testing can lower the risk of Down Syndrome in your baby – PINKVILLA

The specific genetic test that can help is known as preimplantation genetic testing for aneuploidies (PGT-A). It helps to select embryos that are the most likely to result in a successful pregnancy and reduces the chance of having your child having an extra or missing chromosome, an event that causes events such as Down syndrome.

While having a child is a joy couples look forward to, genetic disorders can dampen the feeling. It may also affect the quality of life of the child. Not all genetic disorders happen only because one or both the parents carry a faulty gene; some, like the Down Syndrome, may also happen due to the advanced age of the mother. At a time when more and more women are marrying late and having their child much later than their previous generations, the incidence of such disorders is likely to increase. According to research, maternal age at delivery is directly linked to the risk of aneuploidy (presence of an abnormal number of chromosomes in a cell) in the child at 30, 35, 38, 40, 45 and 49 years of age of the mother, the risk of aneuploidy was found to be 1 in 385 (or 0.26%), 1 in 192 (or 0.52%), 1 in 102 (or 0.98%), 1 in 66 (or 1.5%), 1 in 21 (or 4.8%) and 1 in 8 (or 12.5%), respectively.

What is Down Syndrome & its health impact and causes?

Down syndrome or Down's syndrome is also known as trisomy 21 and occurs in approximately 1 of 830 live births. It is a genetic disorder caused an aneuploidy by the presence of all or part of the third copy of chromosome 21 and is associated with a delay in physical growth, mild to moderate cognitive and intellectual disability, and characteristic facial features such as a flat face, especially the bridge of the nose, almond-shaped eyes that slant up, a short neck, and small ears. In fact, Down syndrome can alone account for 15 to 20 per cent of the population with intellectual disability (ID) across the world. They are also likely to be shorter in height as children and adults. Many who are born with it can grow up as individuals with leukaemia, heart defects, early-onset Alzheimer's disease, gastrointestinal problems, and other health issues. Interestingly, though Down Syndrome is one of the commonest birth defects noted in India, its prevalence in the tribal population is not known.

Preventing Down Syndrome

While preventing Down syndrome may not be possible, scientific advancements in the field of reproductive genetics since the 1990s have made it possible to minimise the chance of a child being born with Down Syndrome to near zero. This technology, known as preimplantation genetic screening (PGS), a preventative measure used to identify chromosomal abnormalities and abnormalities in chromosome position, known as translocations, in an embryo, even if none of the parents have any known genetic disease. Yes, having a child without Down syndrome is possible by combining in-vitro fertlisation (IVF) with preimplantation genetic screening or PGS (testing embryos from parents with no known genetic disorders). The specific genetic test that can help is known as preimplantation genetic testing for aneuploidies (PGT-A). It helps to select embryos that are the most likely to result in a successful pregnancy and reduces the chance of having your child having an extra or missing chromosome, an event that causes events such as Down syndrome. Do not mistake it for preimplantation genetic diagnosis (PGD), a testing method that helps identify as many as 400 genetic defects in embryos as young as 5 days before they are implanted in the womb.

While PGD (testing embryos from parents, one or both of who have a genetic abnormality) helps couples with history of multiple failed IVFs, or multiple missed abortions or miscarriages, PGS is recommended for women aged 38 or more, or those who have a history of miscarriages and failed IVF or implantation. If a woman is going to be a mother in her late 30s or already has a child with Down Syndrome, having a pre-conception counselling may prove helpful you doctor may also refer you to a genetic counsellor who can guide about the risks to enable the would-be parents take an informed decision.

About the author: By Dr. Gauri Agarwal Fertility Expert & Founder of Seeds of Innocence & Genestrings Lab

ALSO READ: All that you need to know about Cancer pain and how to deal with it

x Your comment has been submitted to the moderation queue

Excerpt from:
EXCLUSIVE: THIS genetic testing can lower the risk of Down Syndrome in your baby - PINKVILLA

Researchers identify rare genetic syndrome caused by gene mutations – Health Europa

Advances in DNA sequencing have uncovered three classes of mutations within the gene SATB1, which result in three variations of a neurodevelopmental disorder with varying symptoms ranging from epilepsy to muscle tone abnormalities.

The study, co-authored by academics from Oxford Brookes University, University of Lausanne, Radboud University, University of Oxford, University of Manchester, and led by Max Planck Institute for Psycholinguistics (The Netherlands), identified 42 patients with mutations in the gene SATB1 who were all displaying a range of similar symptoms, with varying severity.

The newly identified SATB1-syndrome is characterised by neurodevelopmental delay, intellectual disability, muscle tone abnormalities, epilepsy, behavioural problems, facial dysmorphism, and dental abnormalities.

Dr Dianne Newbury, Senior Lecturer in Medical Genetics and Genomics at Oxford Brookes University said: Previously, just one or two cases of patients with SATB1 variations had been described but it was not recognised as a specific syndrome. Patients displaying these characteristics and their families, will have known that they had an undefined neurological condition, but they wouldnt have known any specific detail about the condition, or why they had it.

We hope that the recognition of this new disorder, and the information about the molecular pathways contributing to it, will help the families and individuals affected understand more about the condition and achieve a diagnosis they would not have had previously.

The mutations were found to belong to three different classes with the first mutation class causing a loss of function of the SATB1 gene and halving the production of the encoded protein, leading to a less severe syndrome characterised by diminished cognitive function, visual problems, and facial dysmorphism.

The second class of mutations encode shorter proteins that are less efficient, ad shows as an intermediary syndrome, characterised as more severe than the first, but less severe than the third.

The third class modify the encoded protein, making it more active. This altered protein is sticky and binds better to DNA, diminishing the expression of genes it regulates and causing a more severe type of disorder, characterised by severe intellectual disability, epilepsy, a motor speech disorder (dysarthria) and specific facial features.

Dr Alexandre Reymond, Director of the Center for Integrative Genomics at the University of Lausanne in Switzerland said: These results demonstrate that each mutation is different and that is essential to understand their mode of action in order to explain the origin of genetic diseases. We must go beyond sequencing, which is only a first step.

The paper, Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction, has been published in The American Journal of Human Genetics.

Here is the original post:
Researchers identify rare genetic syndrome caused by gene mutations - Health Europa

Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them – CNN

They couldn't explain why those afflicted, often in the same family, had recurring fevers, abdominal pain, troublesome rashes and muscle aches. Known as familial Mediterranean fever, the disease often went undiagnosed for years, and it was sometimes fatal.

A similar, but unrelated, mystery fever was initially thought to affect families with Scottish and Irish heritage.

"The pain I felt back then, it moved around. One week the pain was in my leg, and the next week my arm would hurt instead," said Victoria Marklund, 47, a Swedish woman who suffered from TRAPS, or tumor necrosis factor receptor-associated periodic syndrome, a disease first identified in a family of Irish and Scottish descent living in the UK city of Nottingham in 1982.

Her father and grandfather died prematurely from kidney complications, which were likely a consequence of the undiagnosed disorder.

Marklund has now received an effective treatment and lives symptom-free -- largely thanks to the work of one US physician and health researcher, Dr. Dan Kastner, a distinguished investigator at the National Institutes of Health who serves as scientific director of the National Human Genome Research Institute.

"What Dr. Kastner has accomplished is absolutely groundbreaking. The concept of autoinflammatory disorders didn't exist before he identified the cause behind a number of them," said Olle Kmpe, a professor of clinical endocrinology at Karolinska Institutet in Stockholm who is a member of The Royal Swedish Academy of Sciences and chair of the Prize Committee. The academy also selects Nobel laureates.

"His discoveries have taught us a great deal about the immune system and its functions, contributing to effective treatments that reduce the symptoms of disease from which patients previously suffered enormously," Kmpe added.

Breakthrough

Kastner first came across familial Mediterranean fever in a patient with recurring arthritis and high fevers he treated as a rheumatology fellow just months into his first job at the NIH in Bethesda, Maryland, in 1985. That chance diagnosis set him on a 12-year journey to find the gene -- or genes -- responsible for the disease.

"It was known that familial Mediterranean fever was a genetic disease. It was known that it was recessively inherited, but no one knew what the gene was, or even the chromosome," he said.

He traveled to Israel, where he took blood samples from 50 families with familial Mediterranean fever.

It took Kastner seven years to locate the mutation to chromosome 16. It took another five years -- in 1997 -- for Kastner and his team to find the mutated gene itself -- one misprint in a genetic code comprised of 3 billion letters.

After this breakthrough, he stayed at NIH, where he studied undiagnosed patients with similar symptoms. He identified 16 autoinflammatory genetic disorders and found effective treatments for at least 12 of them, establishing a whole new field of medicine.

Now that the full human genome has been mapped, the process of detecting the genetic root of such disorders is quicker, and greater numbers of patients with these rare, unexplained diseases are being helped as a result of Kastner's work.

All-nighters

There are few images in science more iconic than the DNA double helix structure, discovered in 1953 by James Watson and Francis Crick, two years after Kastner was born. As a seventh grader, he once created a version of the twisted ladder shape using jelly beans and pipe cleaners for a science fair.

His work to identify the gene that caused familial Mediterranean fever had its own element of competition. In the summer of 1997, to beat a rival team led by French researchers, Kastner took a last-minute flight from Bethesda, Maryland, where the NIH is based, to Boston to submit his manuscript detailing the gene mutation that caused familial Mediterranean fever by hand to the journal Cell on a Friday afternoon.

These were the days before papers could be submitted with the click of a mouse. He hoped to publish his work first. Ultimately, the two teams published their papers simultaneously in different journals -- both fortunately arriving at the same finding.

"I love that type of thing," he said. "We still have races to the finish, and there's nothing like a good week of all-nighters."

Kastner had discovered that the gene involved in familial Mediterranean fever produces a protein called pyrin. Normally this helps to activate our innate immune system -- our first line of defense to fight bacteria and viruses.

In this case, however, pyrin made the innate immune system become overactive, resulting in fever, pain and joint inflammation. He went on to study patients with similar and more devastating symptoms -- identifying TRAPS and many more rare diseases.

Transforming lives

What has motivated Kastner for five decades is how his work decoding the genetics of inflammation can inform new treatments and ultimately transform patients' lives.

"There's nothing more gratifying in life and nothing more satisfying scientifically," he said. He plans to step down from his role as scientific director at the NIH in the next few months and then focus his efforts on his clinic, where he has over 3,000 patients enrolled and "find yet more disease genes, understand how they work, and develop new treatments."

"Of course, one can never know how long that will last, but I love doing it, and will continue as long as I can."

In more recent work beginning in 2014, Kastner identified and pioneered treatment for a severely debilitating genetic disorder known as DADA2, short for deficiency of the enzyme ADA2 (adenosine deaminase 2), which can cause recurring fevers and strokes starting in childhood. His research has radically improved the life of the daughter of Dr. Chip Chambers.

"She's now at college and the improvement in her quality of life has been dramatic."

Similarly, TRAPS survivor Marklund suffered for years before her diagnosis at the age of 38. Her nephews, who both have TRAPS but have been given medicine from an early age, don't feel the effects of the disease at all, she told The Royal Swedish Academy Of Sciences.

"I doubted many times that anyone would ever figure out what I was suffering from. So now it feels fantastic, to be told what it was, to understand the cause of the disease and that there is medicine that helps."

Here is the original post:
Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN

Genetic analysis of symptoms yields new insights into PTSD – Yale News

Attempts to identify the genetic causes of neuropsychiatric diseases such as post-traumatic stress disorder (PTSD) through large-scale genome-wide analyses have yielded thousands of potential links. The challenge is further complicated by the wide range of symptoms exhibited by those who have PTSD. For instance, does extreme arousal, anger, or irritation experienced by some have the same genetic basis as the tendency to re-experience traumatic events, another symptom of the disorder?

A new study led by researchers at Yale and the University of California-San Diego (UCSD) provides answers to some of these questions and uncovers intriguing genetic similarities between PTSD and other mental health disorders such as anxiety, bipolar disorder, and schizophrenia.

The findings also suggest that existing drugs commonly used for other disorders might be modified to help treat individual symptoms of multiple disorders.

The complexity is still there, but this study helped us chip away at it, said co-senior author Joel Gelernter, theFoundations Fund Professor of Psychiatry and professor of genetics and neurobiology at Yale.

The study was publishedJan. 28 in the journal Nature Genetics.

For the study, the researchers analyzed the complete genomes of more than 250,000 participants in theMillion Veteran Program, a national research program of the U.S. Veterans Administration that studies how genes, lifestyle, and military experiences affect the health and illness of military veterans. Among those participants were approximately 36,000 diagnosed with PTSD.

But instead of looking just for gene variants shared by PTSD patients, they also searched for variants that have been linked to three kinds of clinical symptoms that are experienced, to varying degrees, by those diagnosed with the disorder. These symptom groups, or subdomains, include the re-experience of a traumatic event, hyperarousal or acute anger and irritability, and the avoidance of people or subjects that might be related to past trauma.

While the researchers found underlying genetic commonalities among all three symptom groups, they also discovered specific variants linked to only one or two of the symptoms.

We found a remarkably high degree of genetic relatedness between these three symptom subdomains. But we also wouldnt expect them to be genetically identical, and they are not, Gelernter said. We found biological support for different clinical presentations of PTSD.

The research also showed that some these variants found in subgroups of patient symptoms are also linked to other disorders such as major depression. The results suggest drugs used to treat other disorders might also help treat of PTSD.

Our research pointed to some medications that are currently marketed for other disease states and could be repurposed for PTSD, said co-senior author Murray Stein, Distinguished Professor of Psychiatry and Public Health at UC-San Diego.

Intriguingly, some of the variants linked to all PTSD symptoms have been associated with other neuropsychiatric disorders. For instance, PTSD-associated variants of the geneMAD1L1,which helps regulate cell cycling, have also been linked to schizophrenia and bipolar disorder.

These observations, and the recent finding of GWS [genomewide-significant] association with anxietysuggest thatMAD1L1may be a general risk factor for psychopathology, the authors write.

Visit link:
Genetic analysis of symptoms yields new insights into PTSD - Yale News

Deep Learning Shows How Genetic Motifs Conduct the Music of Life – Technology Networks

Our genetic codes control not only which proteins our cells produce, but also to a great extent in what quantity. This ground-breaking discovery, applicable to all biological life, was recently made by systems biologists at Chalmers University of Technology, Sweden, using supercomputers and artificial intelligence. Their research, which could also shed new light on the mysteries of cancer, was recently published in the scientific journal Nature Communications.

DNA molecules contain instructions for cells for producing various proteins. This has been known since the middle of the last century when the double helix was identified as the information carrier of life.

But until now, the factor which determines what quantity of a certain protein will be produced has been unclear. Measurements have shown that a single cell can contain anything from a few molecules of a given protein, up to tens of thousands.

With this new research, our understanding of the mechanisms behind this process, known as gene expression, has taken a big step forward. The group of Chalmers scientists have shown that most of the information for quantity regulation is also embedded in the DNA code itself. They have demonstrated that this information can be read with the help of supercomputers and AI.

You could compare this to an orchestral score. The notes describe which pitches the different instruments should play. But the notes alone do not say much about how the music will sound, he explains.

Information for the tempo and dynamics of the music are also required, for example. But instead of written instructions such asallegroorfortein connection with the notation, the language of genetics spreads this information over large areas of the DNA molecule. Previously, we could read the notes, but not how the music should be played. Now we can do both, states Aleksej Zelezniak.

Another comparison could be that now we have found the grammar rules for the genetic language, where perhaps before we only knew the vocabulary.

What then is this grammar, which determines the quantity of gene expression? According to Aleksej Zelezniak, it takes the form of reoccurring patterns and combinations of the four notes of genetics the molecular building blocks designated A, C, G and T. These patterns and combinations are known as motifs.

The crucial factors are the relationships between these motifs how often they repeat and at exactly which positions in the DNA code they appear.

We discovered that this information is distributed over both the coding and non-coding parts of DNA meaning, it is also present in the areas that used to be referred to as junk DNA.

The researchers tested the method in seven different model organisms from yeast and bacteria to fruit flies, mice, and humans and found that the mechanism is the same. The discovery they have made is universal, valid for all biological life.

According to Aleksej Zelezniak, the discovery would have not been possible without access to state-of-the-art supercomputers and AI. The research group conducted huge computer simulations both at Chalmers University of Technology and other facilities in Sweden.

This tool allows us to look at thousands of positions at the same time, creating a kind of automated examination of DNA. This is essential for being able to identify patterns from such huge amounts of data.

Jan Zrimec, postdoctoral researcher in the Chalmers group and first author of the study, agrees, saying:

With previous technologies, researchers had to tell the system which motifs in the DNA code to search for. But thanks to AI, the system can now learn on its own, identifying different motifs and motif combinations relevant to gene expression.

He adds that the discovery is also due to the fact they were examining a much larger part of DNA in a single sweep than had previously been done.

The new knowledge could also make it possible to better understand how mutations can affect gene expression in the cell and therefore, eventually, how cancers arise and function. The applications which could most rapidly be significant for the wider public are in the pharmaceutical industry.

It is conceivable that this method could help improve the genetic modification of the microorganisms already used today as biological factories leading to faster and cheaper development and production of new drugs, he speculates.

Reference: Zrimec J, Brlin CS, Buric F, et al. Deep learning suggests that gene expression is encoded in all parts of a co-evolving interacting gene regulatory structure. Nat Commun. 2020;11(1):6141. doi:10.1038/s41467-020-19921-4.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

See the rest here:
Deep Learning Shows How Genetic Motifs Conduct the Music of Life - Technology Networks

Genetics project of Troy High grads sent to the international space station – C&G Newspapers

Former Troy High School students Finsam Samson and Yujie Wang were selected to have their proposed DNA experiment transported to the International Space Station.

Advertisement

TROY A science experiment created by two former Troy High School students has been sent to the International Space Station with the launch of SpaceXs Falcon 9 rocket in November.

Now college students, Finsam Samson and Yujie Wang began their experiment, Genes in Space 7, while attending Troy High and graduating with the Class of 2019.

In May 2019, the former students became one of five national team finalists in the NASA Genes in Space competition. As part of the program, they received mentorship from the Massachusetts Institute of Technology and Harvard scientists, attended Biology Space Camp, presented their research at a science conference, and were selected to have their proposed DNA experiment transported to the International Space Station with the SpaceX crew, which blasted off in November.

The students and their mentors gave the astronauts genetic material extracted from fruit flies with the goal of learning more about how spaceflight affects brain function.

We established a method by which we can look at how long-term space flight can impact neural function, Samson, now a sophomore at Stanford University, said in a statement.

It really feels like being part of something monumental, Wang, who currently attends the University of California, Berkeley, added.

The students mentor, Matthew Smith, from Harvard University, said the experiment is a basic test of the protocol to see if it works on the International Space Station and if it is something the astronauts can carry out easily.

The accomplishment has made the Troy School District proud, according to Troy High AP biology teacher Rebecca Brewer.

As their AP biology teacher, Brewer said, she is extremely proud to see her former students dedication and innovativeness translate into winning the competition.

I am certain this accomplishment is only the beginning and will send them on a trajectory to future successes in the sciences. They serve as role models to all my current members of Troy Highs Biology Competition Club that with creativity plus intellect plus tenacity, anything is possible, she said in a statement.

The historic mission teaming SpaceX and NASA was part of the first official crew-rotation mission from America in nearly a decade. The mission, sending four astronauts to the International Space Station, successfully launched from Kennedy Space Center in Florida on Sunday, Nov. 15, 2020, and was broadcast live on several news outlets. After a trip of some 27.5 hours in orbit, the Crew-1 astronauts docked with the International Space Station Nov. 16 and began a six-month stay.

We perform a wide variety of science ranging everywhere from biological to physical sciences, as well as earth and space sciences, NASA ISS Deputy Chief Scientist Jennifer Buchli said in a statement

Advertisement

The rest is here:
Genetics project of Troy High grads sent to the international space station - C&G Newspapers

Huntsville Hospital, Kailos Genetics work to prevent coronavirus outbreaks in the workplace – WAAY

Huntsville Hospital and Kailos Genetics are teaming up to offer COVID-19 testing for businesses. Basically, all they have to do is sign up and get tested.

Troy Moore with Kailos Genetics said they're making it easy for businesses to reduce outbreaks in an office.

"The Huntsville hospital staff comes on sight and they perform the collection, and then, they bring the samples back to Kailoss lab over at HudsonAlpha," said Moore.

Businesses can sign up for weekly sentinel testing. Kailos Genetics created a viral wash as a less invasive way to get tested for COVID-19. You will get the results back within four days.

The CEO of Huntsville Hospital, David Spillers, said testing for the virus is vital.

If anything, I think testing has become more important going forward than it has been in the past, particularly with these new strains," he said.

The testing Kailos Genetics uses is able to detect both the COVID-19 we've been seeing and the new variants. Moore said consistent testing is key to reducing COVID-19 in a workplace.

What were looking for is to identify those that are carrying the virus, or have been exposed but arent showing symptoms yet, take them back out before they spread it to others, or catch those people that have been exposed very early so they dont, you know, obviously dont spread it to more," Moore said.

Moore said they will discuss with the businesses how frequently they should do sentinel testing based on individual risk factors.

Read more here:
Huntsville Hospital, Kailos Genetics work to prevent coronavirus outbreaks in the workplace - WAAY